Recordati SpA (MTA:REC)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - REC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - REC

  • Market Cap€9.822bn
  • SymbolMTA:REC
  • IndustryHealthcare
  • Sector-
  • Currency
  • ISINIT0003828271

Company Profile

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth strategy. The vast majority of the company's revenue is generated in Italy, followed by France and Germany. Recordati reports two operating segments: specialty and primary care and rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.Recordati is a drug manufacturing company which produces and promotes medicines globally, focused on primary-care therapies and rare diseases.

Latest REC news

Currently there for this company. Visit our news hub for other news .